Mindset Pharma IncChange company Symbol lookupSelect an option...MSSTF Mindset Pharma IncRENE Cartesian Growth Corporation IIDTCFF Defence Therapeutics IncSTKH Steakholder Foods LtdADBE Adobe IncFATP Fat Projects Acquisition CorpLGVC LAMF Global Ventures I CorpSECO Secoo Holding LtdSGBXV Safe & Green Holdings CorpCAH Cardinal Health IncGo
Change company Symbol lookup
Select an option...
MSSTF Mindset Pharma Inc
RENE Cartesian Growth Corporation II
DTCFF Defence Therapeutics Inc
STKH Steakholder Foods Ltd
ADBE Adobe Inc
FATP Fat Projects Acquisition Corp
LGVC LAMF Global Ventures I Corp
SECO Secoo Holding Ltd
SGBXV Safe & Green Holdings Corp
CAH Cardinal Health Inc
Health Care : Pharmaceuticals |
Based in Canada
Company profileBased in Canada
Mindset Pharma Inc. is a Canada-based drug discovery and development company focused on creating optimized and patentable psychedelic medicines to treat neurological and psychiatric disorders with unmet needs. The Company is developing various families of psychedelic compounds, as well as a process to chemically synthesize psilocybin in addition to its own proprietary compounds. The Company, through the McQuade Center, covers multiple drug development programs. The Company has developed 4 families of next-generation psychedelics with differentiated characteristics. The Company's portfolio consists of macrodosing and microdosing. Its macrodosing includes Family 1/MSP-1014, Family 2, and Family 4. The MSP-1014 is a new chemical entity that incorporates a conjugated amplifier into a psilocybin-like structure to create an effective drug. The Company's Family 3 is a long-acting next-generation psychedelic drug positioned for micro-dosing.
|
|
|
|
| |
| Latest Earnings Missed Consensus (Q4 ending 06/2023) | Next Earnings Announcement | ||||||
|---|---|---|---|---|---|---|---|
| Q4 Non-GAAP earnings GAAP vs. Non-GAAP EarningsTD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. Announced August 1, 2023 | -$0.12 | Q4 Consensus of 2 analysts | -$0.02 | Difference from consensus | -540.00% | Q1 Earnings will announce | -- |
Quarterly Earnings History and Estimates
Show high-low estimates
Draw trendlines
Draw up to 3 lines inside the chart.
MSSTF's fiscal year ends in June
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.
Information provided by Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.